Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
  1. 4 Grant or award Director acquired 10,139 shares (grant or award)
  2. 4 Grant or award Director acquired 10,139 shares (grant or award)
  3. 4 Grant or award Director acquired 10,139 shares (grant or award)
  4. 4 Grant or award Director acquired 10,139 shares (grant or award)
  5. 4 Grant or award Director acquired 10,139 shares (grant or award)
  6. 4 Grant or award Director acquired 10,139 shares (grant or award)
  7. 4 Grant or award Director acquired 10,139 shares (grant or award)
  8. 4 Open-market sale Director sold 10,000 shares at an average $8.01 ($80,092)
  9. 4 Open-market sale Burnett Patrick sold 72,952 shares at an average $8.73 ($636,706)
  10. 4 Planned sale Matsuda Masaru sold 1,775 shares at $9.01 ($15,988)
  11. 4 Open-market sale SVP Chief Commercial Officer sold 7,640 shares at $8.98 ($68,582)
  12. 4 Planned sale SVP and Chief Business Officer sold 4,681 shares at $8.74 ($40,902)
  13. 4 Planned sale Watanabe Todd Franklin sold 13,783 shares at $8.74 ($120,433)
  14. 4 Planned sale Matsuda Masaru sold 5,016 shares at $8.74 ($43,829)
  15. 4 Planned sale Burnett Patrick sold 9,555 shares at $8.74 ($83,490)
  16. 4 Grant or award Chief Financial Officer acquired 110,000 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Planned sale Matsuda Masaru sold 3,760 shares at $11.12 ($41,816)
  19. 4 Planned sale Burnett Patrick sold 4,782 shares at $11.12 ($53,182)
  20. 4 Planned sale Watanabe Todd Franklin sold 14,903 shares at $11.12 ($165,739)

Page 9 of 23 · 452 filings